Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,207,045
-
Share change
-
+212,201
-
Total reported value
-
$774,808,496
-
Put/Call ratio
-
38%
-
Price per share
-
$12.87
-
Number of holders
-
125
-
Value change
-
-$49,532,312
-
Number of buys
-
83
-
Number of sells
-
64
Institutional Holders of ENDOLOGIX INC - COM (ELGX) as of Q1 2014
As of 31 Mar 2014,
ENDOLOGIX INC - COM (ELGX) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,207,045 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, PALISADE CAPITAL MANAGEMENT LLC/NJ, Clearbridge Investments, LLC, WELLS FARGO & COMPANY/MN, KING LUTHER CAPITAL MANAGEMENT CORP, EAGLE ASSET MANAGEMENT INC, and BlackRock Institutional Trust Company, N.A..
This page lists
125
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.